Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Albireo: A Speculative Play With Upside
May, 03 2022 02:06 PM
Bristol-Myers Squibb Company
The lead medicine (Bylvay) is already approved to treat an orphan disease known as progressive familial intrahepatic cholestasis. Leveraging a prudent growth strategy, Albireo is aggressively expanding Bylvay's label for other rare conditions. Due to the biotech bear market, the stock is trading at a deep bargain to its intrinsic value which widens the margin of safety for investment. For further details see:
Albireo: A Speculative Play With Upside
Stock Information
Company Name:
Bristol-Myers Squibb Company
Stock Symbol:
BMY
Market:
NYSE
Website:
bms.com
Get BMY Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .